Globus Medical Reports 2Q18 Revenue
Globus Medical reported 2Q18 revenue of US $173.4MM, +13.8% vs. 2Q17, and 1H18 revenue of $347.8MM, +12.8% vs. 1H17. Aug 03, 2018
K2M Announces 2Q18 Revenue
K2M posted 2Q18 revenue of US $73.6MM, +12.0% vs. 2Q17, and 1H18 revenue of $141.5MM, +10.9% vs. 1H17. Aug 03, 2018
BONESUPPORT Signs Strategic Agreement with MTF Biologics
BONESUPPORT entered into an agreement with MTF Biologics, gaining U.S. rights to distribute two demineralized bone matrices. Aug 02, 2018
NuVasive 2Q18 Revenue +8.5% vs. 2Q17
NuVasive reported 2Q18 revenue of US $281.6MM, +8.5% vs. 2Q17, and 1H18 revenue of $542.1MM, +6.6% vs. 1H17. Aug 02, 2018
RTI and Aziyo Partner on ViBone Cellular Matrix
RTI Surgical and Aziyo Biologics signed an agreement for RTI's exclusive U.S. distribution of ViBone® cellular bone matrix. Aug 02, 2018
OrthoPediatrics Announces Expanded Indication for FIREFLY Pedicle Screw Navigation
OrthoPediatrics announced an additional FDA 510(k) clearance for the FIREFLY® Pedicle Screw Navigation Guide to include S2AI screw trajectory for sacral-iliac fixation in complex spinal reconstruction. Aug 01, 2018
SeaSpine 2Q18 Revenue +7% vs. 2Q17
SeaSpine announced 2Q18 revenue of US $36.4MM, +6.5% vs. 2Q17, and 1H18 revenue of $69.6MM, +5.3% vs. 1H17. This is the company's highest quarterly growth rate since its spinoff from Integra LifeSciences in 2015. Aug 01, 2018
Zimmer Biomet Ortho Revenue +4% vs. 2Q17
ORTHOWORLD estimates Zimmer Biomet 2Q18 orthopaedic revenue of US $1,858.2MM, +3.5% vs. 2Q17, and 1H18 revenue of $3,714.8MM, +2.8% vs. 1H17. Aug 01, 2018
Cerapedics Enrolls Patients in IDE Study of P-15L Bone Graft in TLIF
Cerapedics enrolled the first patients in an IDE clinical trial evaluating P-15L Bone Graft vs. autograft in TLIF. Jul 30, 2018
Integra LifeSciences Reports 2Q18 Revenue
ORTHOWORLD estimates Integra LifeSciences'Â 2Q18 orthopaedic revenue at US $30.4MM, -0.6% vs. 2Q17, and 1H18 revenue of $55.2MM, -2.5% vs. 1H17. Jul 30, 2018
